IP Library Assignment 052312/0930
Patent Assignment
Reel/Frame 052312/0930

Intellectual Property Security Agreement

Recorded: 2020-04-03 Pages: 28
Assignor
GENEVANT SCIENCES LTD.
Executed: 2020-03-27
Assignee
ROIVANT SCIENCES LTD.
11-12 ST. JAMES'S SQUARE, SUITE 1, LONDON, SW1Y 4LB, UNITED KINGDOM
Covered Properties (59)
Bispecific Intracellular Delivery Vehicles
Application: 14/957,429 →
Publication: US 2016/0082121
Bispecific Intracellular Delivery Vehicles
Application: 61/171,381 →
Block Copolymers
Application: 15/827,793 →
Publication: US 2018/0243433
Block Copolymers
Application: 61/860,136 →
Block Copolymers
Application: 61/868,122 →
Branched Peg Molecules and Related Compositions and Methods
Application: 16/475,006 →
Publication: US 2020/0078313
Branched PEG Molecules and Related Compositions and Methods
Application: 62/440,941 →
Branched PEG Molecules and Related Compositions and Methods
Application: 62/446,186 →
Diblock Copolymer Micelles and Polynucleotide Complexes Thereof for Delivery into Cells
Application: 61/091,294 →
Diblock Copolymers and Polynucleotide Complexes Thereof for Delivery into Cells
Application: 15/828,078 →
Publication: US 2018/0171056
Diblock Copolymers and Polynucleotide Complexes Thereof for Delivery into Cells
Application: 61/052,908 →
Diblock Copolymers and Polynucleotide Complexes Thereof for Delivery into Cells
Application: 61/171,377 →
ENDOSOMOLYTIC DIBLOCK COPOLYMER FOR siRNA DELIVERY
Application: 61/052,914 →
Folate and Folate Analog Targeting Monomers and Polymers Having Folate or Folate Analog Targeting Blocks
Application: 61/262,516 →
Methods, Compositions, and Systems for Delivering Therapeutic and Diagnostic Agents into Cells
Application: 15/545,302 →
Publication: US 2018/0221402
Methods, Compositions, and Systems for Delivering Therapeutic and Diagnostic Agents into Cells
Application: 62/106,024 →
Methods, Compositions, and Systems for Delivering Therapeutic and Diagnostic Agents into Cells
Application: 62/173,847 →
Methods, Compositions, and Systems for Delivering Therapeutic and Diagnostic Agents into Cells
Application: 62/233,568 →
Micelles for Intracellular Delivery of Therapeutic Agents
Application: 12/992,541 →
Publication: US 2011/0142951
Micelles of Hydrophilically Shielded Membrane-Destabilizing Copolymers
Application: 13/127,962 →
Publication: US 2011/0281934
Micellic Assemblies
Application: 16/579,662 →
Publication: US 2020/0147121
Micellic Assemblies
Application: 61/112,048 →
Micellic Assemblies
Application: 61/140,774 →
Micellic Assemblies
Application: 61/171,369 →
Multiblock Copolymers
Application: 15/254,874 →
Publication: US 2017/0049801
Multiblock Copolymers
Application: 61/177,921 →
Multiblock Copolymers
Application: 61/243,898 →
Nucleic Acid Constructs and Methods of Using the Same
Application: 16/543,324 →
Publication: US 2019/0388551
Omega-Functionalized Polymers, Junction-Functionalized Block Copolymers, Polymer Bioconjugates, and Radical Chain Extension Polymerization
Application: 61/120,756 →
Ornithine Transcarbamylase (Otc) Constructs and Methods of Using the Same
Application: 62/924,567 →
Polymeric Carrier
Application: 14/630,477 →
Publication: US 2015/0238619
Polymeric Carrier
Application: 61/112,054 →
Polymeric Carrier
Application: 61/140,779 →
Polymeric Carrier
Application: 61/171,358 →
Targeted Polymer Bioconjugates
Application: 12/992,545 →
Publication: US 2011/0129921
Targeted Polymer Bioconjugates
Application: 61/120,769 →
Targeted Polymer Bioconjugates
Application: 61/171,365 →
Targeting Monomers and Polymers Having Targeting Blocks
Application: 61/262,512 →
Therapeutic Methods
Application: 62/755,196 →
Lipid Nanoparticles
Application: 62/839,452 →
Lipid Nanoparticles
Application: 62/867,098 →
Conjugates and Methods for Treating Acromegaly
Application: 62/925,659 →
Conjugates and Methods for Treating Liver Fibrosis
Application: 62/944,963 →
Cationic Lipids for Lipid Nanoparticle Delivery of Therapeutics to Hepatic Stellate Cells
Application: 62/975,116 →
Cationic Lipids for Lipid Nanoparticle Delivery of Therapeutics to Hepatic Stellate Cells
Application: 62/990,939 →
Bispecific Intracellular Delivery Vehicles
Patent: 8,822,213 →
Application: 13/127,968 →
Publication: US 2011/0281354
Bispecific Intracellular Delivery Vehicles
Patent: 9,220,791 →
Application: 14/173,730 →
Publication: US 2014/0228516
Block Copolymers
Patent: 9,867,885 →
Application: 14/908,351 →
Publication: US 2016/0206750
Diblock Copolymers and Polynucleotide Complexes Thereof for Delivery into Cells
Patent: 9,476,063 →
Application: 12/992,517 →
Publication: US 2011/0143434
Diblock Copolymers and Polynucleotide Complexes Thereof for Delivery into Cells
Patent: 9,862,792 →
Application: 15/264,392 →
Publication: US 2017/0096517
Heterogeneous Polymeric Micelles for Intracellular Delivery
Patent: 9,211,250 →
Application: 13/059,946 →
Publication: US 2012/0021514
Micellic Assemblies
Patent: 9,339,558 →
Application: 12/992,525 →
Publication: US 2011/0123636
Micellic Assemblies
Patent: 9,662,403 →
Application: 15/059,026 →
Publication: US 2016/0250338
Micellic Assemblies
Application: 15/499,683 →
Publication: US 2017/0239360
Multiblock Copolymers
Patent: 9,464,300 →
Application: 13/127,959 →
Publication: US 2011/0286957
Omega-Functionalized Polymers, Junction-Functionalized Block Copolymers, Polymer Bioconjugates, and Radical Chain Extension Polymerization
Patent: 9,593,169 →
Application: 13/133,355 →
Publication: US 2011/0305660
Omega-Functionalized Polymers, Junction-Functionalized Block Copolymers, Polymer Bioconjugates, and Radical Chain Extension Polymerization
Application: 15/428,063 →
Publication: US 2017/0145141
Polymeric Carrier
Patent: 9,006,193 →
Application: 12/992,536 →
Publication: US 2011/0143435
Targeting Monomers and Polymers Having Targeting Blocks
Patent: 9,415,113 →
Application: 13/510,279 →
Publication: US 2013/0011362
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License Dec 1, 2010
From: UNIVERSITY OF WASHINGTON, CENTER FOR COMMERCIALIZATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025434/0195 →
Assignment of Assignor's Interest Feb 14, 2011
From: JOHNSON, PAUL H.; OVERELL, ROBERT W.; GALL, ANNA S.; PRIEVE, MARY G.
To: PHASERX, INC.
Reel/Frame 025805/0469 →
Assignment of Assignor's Interest Feb 14, 2011
From: STAYTON, PATRICK S.; HOFFMAN, ALLAN S.; CONVERTINE, ANTHONY J.
To: WASHINGTON, UNIVERSITY OF
Reel/Frame 025805/0365 →
Corrective Assignment to Correct the Misspelling of Inventor Paschal's Last Name in the Recordation Cover Sheet from <Pascal> to <Paschal> Previously Recorded on Reel 025805 Frame 0469. Assignor(S) Hereby Confirms the Assignment of Their Application No. 12/992,541, Filed February 8, 2011, to Phaserx, Inc. Apr 13, 2011
From: JOHNSON, PAUL H.; OVERELL, ROBERT W.; GALL, ANNA S.; PRIEVE, MARY G.
To: PHASERX, INC.
Reel/Frame 026122/0392 →
Assignment of Assignor's Interest Jul 26, 2011
From: JOHNSON, PAUL; OVERELL, ROBERT; GALL, ANNA; PRIEVE, MARY
To: PHASERX, INC.
Reel/Frame 026651/0131 →
Assignment of Assignor's Interest Jul 26, 2011
From: STAYTON, PATRICK S.; HOFFMAN, ALLAN S.
To: WASHINGTON, UNIVERSITY OF
Reel/Frame 026649/0233 →
Assignment of Assignor's Interest Feb 7, 2014
From: DECLUE, MICHAEL S.; HARVIE, PIERROT; JOHNSON, RUSSELL N.; MONAHAN, SEAN D.
To: PHASERX, INC.
Reel/Frame 032168/0434 →
Assignment of Assignor's Interest Feb 7, 2014
From: DECLUE, MICHAEL S.; HARVIE, PIERROT; JOHNSON, RUSSELL N.; MONAHAN, SEAN D.
To: PHASERX, INC.
Reel/Frame 032168/0505 →
Assignment of Assignor's Interest May 4, 2015
From: PRIEVE, MARY G.; HOUSTON, MICHAEL E., JR; HARVIE, PIERROT; MONAHAN, SEAN D.
To: PHASERX, INC.
Reel/Frame 035556/0970 →
Assignment of Assignor's Interest Feb 29, 2016
From: PRIEVE, MARY G.; HOUSTON, MICHAEL E., JR.; HARVIE, PIERROT; MONAHAN, SEAN D.
To: PHASERX, INC.
Reel/Frame 037849/0858 →
Assignment of Assignor's Interest Feb 29, 2016
From: PRIEVE, MARY G.; HOUSTON, MICHAEL E., JR.; HARVIE, PIERROT; MONAHAN, SEAN D.
To: PHASERX, INC.
Reel/Frame 037849/0803 →
Confirmatory License Jun 10, 2016
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038955/0552 →
Assignment of Assignor's Interest Mar 15, 2017
From: ROY, DEBASHISH; ELLA-MENYE, JEAN-RENE E.; MONAHAN, SEAN D.; HARVIE, PIERROT
To: PHASERX, INC.
Reel/Frame 041585/0936 →
Assignment of Assignor's Interest Mar 24, 2017
From: ROY, DEBASHISH; ELLA-MENYE, JEAN-RENE E.; MONAHAN, SEAN D.; HARVIE, PIERROT
To: PHASERX, INC.
Reel/Frame 041735/0449 →
Assignment of Assignor's Interest Mar 28, 2017
From: HOUSTON, MICHAEL E.
To: PHASERX, INC.
Reel/Frame 041763/0773 →
Confirmatory License Jun 2, 2017
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 042577/0774 →
Assignment of Assignor's Interest Dec 4, 2017
From: MONAHAN, SEAN D.; DECLUE, MICHAEL S.; HARVIE, PIERROT; JOHNSON, RUSSELL N.
To: PHASERX, INC.
Reel/Frame 044287/0497 →
Assignment of Assignor's Interest Sep 24, 2018
From: JOHNSON, PAUL H.; GALL, ANNA S.
To: PHASERX, INC.
Reel/Frame 046947/0837 →
Assignment of Assignor's Interest Sep 24, 2018
From: OVERELL, ROBERT W.; JOHNSON, PAUL H.
To: PHASERX, INC.
Reel/Frame 046947/0844 →
Assignment of Assignor's Interest Oct 12, 2018
From: ROIVANT HEPATOLOGY GMBH
To: GENEVANT SCIENCES GMBH
Reel/Frame 047689/0406 →
Assignment of Assignor's Interest Oct 12, 2018
From: PHASERX, INC.
To: ROIVANT HEPATOLOGY GMBH
Reel/Frame 047649/0829 →
Confirmatory License Aug 21, 2019
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTE OF HEALTH
Reel/Frame 050120/0038 →
Assignment of Assignor's Interest Jan 21, 2020
From: ROY, DEBASHISH; ELLA-MENYE, JEAN-RENE E.; MONAHAN, SEAN D.; HARVIE, PIERROT
To: PHASERX, INC.
Reel/Frame 051566/0358 →
Assignment of Assignor's Interest Jan 21, 2020
From: PHASERX, INC.
To: ROIVANT HEPATOLOGY GMBH
Reel/Frame 051655/0401 →
Assignment of Assignor's Interest Jan 21, 2020
From: ROIVANT HEPATOLOGY GMBH
To: GENEVANT SCIENCES GMBH
Reel/Frame 051655/0057 →